Why Attend
The massive success of cell and gene therapies in recent years has made the need for effective, large scale vector engineering greater than ever. Though R&D efforts focussed on reducing immunogenicity and toxicity whilst improving redosing ability and durability are showing promise, companies are still striving to optimise these technologies and develop next-generation targeted, persistent and tolerable cell and gene therapies.
The Vector Development for Cell and Gene Therapy Summit is North America’s only event focused exclusively on addressing challenges in vector improvement for both ex vivo and in vivo approaches. Bringing together key industry leaders and covering a range of topics including capsid optimisation using AAV vectors, process optimisation using lentiviral and adenoviral vectors, innovative non-viral delivery options and the importance of vector serotype for improved durability, it’s a key opportunity to gain the actionable insights you’ll need to optimise your manufacturing process and improve tissue-specific targeting and safety profiles for your pipeline.
WHO WILL BE THERE
Network with industry experts from:
- Senior-level leaders from biotech and big pharma
- Internationally-renowned academic experts
- Innovative vector development technology companies
- Service & technology providers – CROs, CDMOs, delivery technology companies and more
Previous Cell Therapy series attendees include:
Get The Agenda
What to Expect:
- Two dedicated tracks focused on in vivo and ex vivo vector optimization (talks from REGENXBIO, Spark Therapeutics, Umoja Biopharma), developing more efficient producer cell lines (talks from Vedere Bio, Ultragenyx, Sanofi) and process development improvements (talks from Pfizer, LogicBio, Bristol Myers Squibb).
- Specific talks and discussion on how to efficiently meet the requirements in bringing drugs to market (Sangamo Therapeutics, Ring Therapeutics).
- Exploration of the most effective vector serotypes to produce more durable gene expression (talks from SparingVision, MIT, Codiak Biosciences, Versatope Therapeutics).
- Discussing the cutting-edge methods to reduce timelines for cell and gene therapy drug development (talks from University of Pennsylvania, Biogen).
- Developing novel vectors to reduce immunogenicity, allowing for effective redosing (talks from SmartImmune, Genethon, UC Berkeley).
Get the agenda
OUR INDUSTRY-LEADING SPEAKERS
Abhishek Chatterjee
Alex Ward
Christopher Locher
David Schaffer
Elad Firnberg
Floris Engelhardt
Georgios Katsikis
Georgios ‘Yorgos’ Katsikis is a postdoctoral associate at MIT. He did his PhD in Mechanical Engineering at Stanford. After his PhD he worked at Carbon, a start-up company in Silicon Valley. He is currently at MIT, researching on nanotechnologies for characterization of viral vectors. For his research, he led a collaboration between three departments at MIT and Biomarin Pharmaceutical. He is interested in biotechnology, microfluidics, biophysics and rapid prototyping.
Giuseppe Ronzitti
Hesong Han
James Richardson
James Voss
Jing Liao
Joseph Gold
Li Ou
Marina Cavazzana
Matthew Fuller
Matt Stebbins
Mauricio Umana
Michael Doherty
Pedro Moura
Rajani Shelke
Rajiv Gangurde
Richard Harbottle
Ryan Crisman
Saba Ghassemi
Sandro Marosevic
Saurabh Sen
Sunandan Saha
Xiaozhi Ren
Zsuzsanna Izsvak
2022 partners
GMP Partner
JAFRAL
Website: https://jafral.com/
JAFARAL is world’s leading CMO for production of bacteriophages, because it’s has more than 10 years’ experience in manufacturing of phages, other biologics production, large scale production and knowing GMP guidelines. Likewise, JAFRAL has all these years also been involved in plasmid DNA and recombinant proteins production at various levels. JAFRAL’s custom development and manufacturing services have helped developers across the globe to accelerate research and open up their laboratories for ground-breaking science and breakthrough discoveries.
Event Partner
Fenix - Cellteligence
Website: https://celltelligence.com/
Please visit our website for more information.Media Partners
Gene Therapy Net
Website: http://www.genetherapynet.com/
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.
Pharma Advancement
Website: https://www.pharmaadvancement.com/advertise-with-us/
Please visit our website for more information.Pharma Journalist
Website: https://www.pharmajournalist.com/
Please visit our website for more information.World Pharma
Website: https://www.worldpharmatoday.com/
Please visit our website for more information.Partner with us
Based on your objectives, we can create bespoke packages designed specifically for you. From presenting your expertise on the main stage to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact Ryan Sanderson, Commercial Partnerships Director at [email protected] or register your interest here.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact Laura Hobson, Senior Marketing Manager; [email protected]
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Saving ends in...
Venue Description
Venue
Hilton Boston Back Bay, 40 Dalton St, Boston, MA 02115, United States
For discounted rooms, please click here.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.